Clinical Trials Directory

Trials / Completed

CompletedNCT01820611

Arcos Revision Stem: Evaluation of Clinical Performance

Status
Completed
Phase
Study type
Observational
Enrollment
74 (actual)
Sponsor
Zimmer Biomet · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The primary purpose of this study is to evaluate the clinical performance of the Arcos Revision Stem system, determine the stability of the implants, and evaluate any relationship between Paprosky bone defect level and the success of the Arcos Stem.

Detailed description

Primary Endpoint: survivorship and revision rate up to 5 years post-operatively Secondary Endpoints: Stability and Fixation of Arcos Hip by radiographic assessment, Relationship between bone defect level and survivorship, Oxford Hip Score and Harris Hip Score post-operative, Adverse events, complications. Case Report Forms: Demographic Data, Paprosky Acetabular/Femoral Defects, Operative Data, Oxford Hip Score, Harris Hip Score, Collection of X-rays, Radiographic Evaluation form, Adverse Events, Revisions, Lost to Follow-up, and Protocol Deviations 200 patients: 100 with BoneMaster HA, 100 without BoneMaster HA. Up to 10 sites globally will be used to fulfill enrollment in this study. All cases enrolled will be those implanted with either the Cone, Broached, or Calcar Proximal Body and one of the five distal options (Slotted, Bullet-tip, Interlocking, STS, or ETO). To be included in the study, a patient must have received a revision total hip arthroplasty with the Arcos system. The Arcos system is to be used in accordance to the indications for use and contraindications detailed in the approved labeling of the device. Study time perspective: Collection of retrospective data in supplement to the data collected in the course of the prospective study to compensate total enrolment goal. This is applicable for 3 sites: Finland, United Kingdom (NHS Sheffield), Spain. All patients enrolled in the study will be followed up as to the same time points for the duration of the study.

Conditions

Interventions

TypeNameDescription
DEVICEArcos Revision Stem SystemRevision Hip System

Timeline

Start date
2013-02-01
Primary completion
2021-06-14
Completion
2021-06-14
First posted
2013-03-29
Last updated
2025-01-20
Results posted
2025-01-20

Locations

5 sites across 4 countries: Finland, Spain, Sweden, United Kingdom

Source: ClinicalTrials.gov record NCT01820611. Inclusion in this directory is not an endorsement.